Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Ticker Scorecard - ACAD

Basics
Company: ACADIA Pharmaceuticals Inc.
IPO Date: June 1, 2004
Sector: Healthcare
Industry: Biotech
Market Cap: $3.33B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.44 | 2.69%
Avg Daily Range (30 D): $0.37 | 1.99%
Avg Daily Range (90 D): $0.32 | 1.87%
Institutional Daily Volume
Avg Daily Volume: 1.19M
Avg Daily Volume (30 D): 2.11M
Avg Daily Volume (90 D): 1.48M
Trade Size
Avg Trade Size (Sh.): 134
Avg Trade Size (Sh.) (30 D): 88
Avg Trade Size (Sh.) (90 D): 79
Institutional Trades
Total Inst.Trades: 9,438
Avg Inst. Trade: $2.22M
Avg Inst. Trade (30 D): $7.67M
Avg Inst. Trade (90 D): $5.82M
Avg Inst. Trade Volume: .09M
Avg Inst. Trades (Per Day): 3
Market Closing Trades
Avg Closing Trade: $3.99M
Avg Closing Trade (30 D): $12.94M
Avg Closing Trade (90 D): $7.36M
Avg Closing Volume: 163.45K
   
News
Feb 11, 2025 @ 8:48 AM
Neuroregeneration Therapy Market to Surpass USD 64...
Source: Transparency Market Research
Jun 27, 2024 @ 12:41 PM
This Vertex Pharmaceuticals Analyst Begins Coverag...
Source: Avi Kapoor
Jun 24, 2024 @ 10:49 AM
Alnylam (ALNY) Soars 5.3%: Is Further Upside Left ...
Source: Zacks Equity Research
Jun 7, 2024 @ 3:30 PM
Acadia (ACAD) Up 0.6% Since Last Earnings Report: ...
Source: Zacks Equity Research
May 9, 2024 @ 9:59 AM
Acadia (ACAD) Q1 Earnings Surpass Estimates, Reven...
Source: Zacks Equity Research
Financials
  TTM Q3 2024 Q2 2024
Basic EPS $.78 $.2 $.2
Diluted EPS $.78 $.2 $.2
Revenue $ 929.24M $ 250.4M $ 241.96M
Gross Profit $ 851.31M $ 231.54M $ 223.73M
Net Income / Loss $ 128.51M $ 32.77M $ 33.39M
Operating Income / Loss $ 112.24M $ 31.64M $ 30.44M
Cost of Revenue $ 77.93M $ 18.86M $ 18.23M
Net Cash Flow $ 60M $ -18.94M $ -27.61M
PE Ratio 25.69